Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    56021927PCR3002
Show Display Options
Rank Status Study
1 Recruiting A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
Condition: Prostate Cancer
Interventions: Drug: Apalutamide;   Drug: Placebo;   Drug: Androgen Deprivation Therapy (ADT)

Study has passed its completion date and status has not been verified in more than two years.